To submit your abstract, you must first be registered for the event. If you are already registered, simply log in to your account and submit as many abstracts as you wish.
The participant who submits the abstract must be the first author, and will be responsible for it before the organization of the event, receiving all the communication and having the certificate linked to your account.
All papers must be submitted to the evaluation of the Scientific and Technological Committee (SCT) of the symposium, in the form of structured abstract, through the form available on the site of the event.
The abstracts accepted by this committee will be published in the event’s annals, will be availlable at the institutional repositor, ARCA, presented as posters during the event and will automatically be eligible for awards.
Some of these papers will be selected by the CCT for oral presentation in the main program of the event.
Criteria for approval of abstracts are:
There is no limit to the number of submitted or co-authored abstracts per participant.
During submission, abstracts should be classified into the following categories: vaccines, biopharmaceuticals, diagnostic reagents, management and others. Up to two areas of knowledge that best characterize the work should be chosen from a list available on the form.
The inclusion of co-authors’ names does not guarantee their participation in the event. If they wish to participate, they will all need to register individually.
Questions and concerns regarding abstract and poster submissions will be decided by the Symposium’s Scientific Committee, which will endeavor to meet all requests in a judicious manner. All decisions of the Committee regarding the acceptance of abstracts will be final and unappealable.
– The abstract consists of a text of maximum 2250 characters (not counting title, authors and institution). The system is programmed not to accept the abstract that exceeds this limit.
– The abstract must be written in English. Texts in Portuguese or languages other than English will not be accepted.
– It cannot contain figures, graphs or tables.
– The text must follow the structure: introduction, objectives, methodology, results and conclusion.
– The title should be typed in lowercase, concisely describing the essence of the subject in up to 20 words.
– When submitting the abstract, the researcher must classify it in the category to which it belongs: V (vaccines), B (biopharmaceuticals), R (reagents), G (management) and ORT (other related topics) and indicate the area of knowledge.
– Abstracts must be submitted via the online form only. Submissions sent via fax, mail, e-mail or other ways beside the website form will not be accepted.
– Authors’ names should be written out in full (maximum of 10 authors). Their titles should not be included: Ex: Doctor, Professor, among others.
– The name of the main author, who is the one submitting the abstract for participation, will be automatically filled in first in the list of authors.
– The first author will be responsible for presenting the work through a recorded video, to be made available to all participants of the event in the poster area or included in the central program of the event. The guidelines for recording this video will be directly forwarded to those responsible for the papers approved in the 7th ISI after evaluation by the CCT.
– We suggest that the text be typed in a text editor before submission, and that each part be pasted in the respective field of the form, taking care that the formatting (such as symbols, superscript and subscript, etc.) is correct.
– The abstract can be submitted by any of the authors, who will be automatically responsible for the work to the organization of the event.
– Insert three keywords in order to clearly identify the subject of the paper. A keyword does not necessarily need to be composed of only one word, it can be an expression, such as: triple viral; liquid microarray; yellow fever; pharmaceutical assistance; evaluation of impacts; good storage and distribution practices.
Authors of abstracts selected by the CCT for participation in the symposium will receive detailed instructions for their participation in communications by e-mail, with guidance on poster construction, video recording and participation times. Register the email isi.biomanguinhos.org as a contact to make sure that communications are not blocked by security mechanisms of your email server.
The Poster Exhibition of the 7th ISI will take place in person during the 3 days of the event, and will also have space in the application as a virtual poster, and should be organised according to the recommendations below:
– As a visual resource, the poster should prioritize the presentation of the paper content through images, graphs and tables rather than long texts.
– Since it will be presented on screens (desktops, laptops and cell phones), the poster should contain the information in the most simplified form possible.
– The background of the poster should be white.
– It is not recommended to use photos as a background, behind the texts and other information, as this makes reading difficult.
– The text of the poster should be read quickly, so it is not advisable to have a long text. Specific information about the reported research will have a greater impact and make it more attractive to read.
– It is not necessary to repeat all the text of the abstract on the poster, as the texts will be available to the participants along with the poster graphic on the paper page.
– To mimic the experience of explaining your poster to visitors, authors can make available a video of up to 5 minutes with a simplified presentation of the poster. Authors selected for the exhibition will receive detailed guidance on how to record this video.
– The making and sending of the poster and video to the event organization is the authors’ responsibility.
– The poster should be organized as follows:
Poster structure: introduction, objectives, methodology, results and conclusion
– The representatives of the approved posters will receive an e-mail with detailed information about the participation in the face-to-face event, the form of submission and the deadlines for sending the files to the virtual application, as well as the date and time for the presentation of the work.
– If the responsible author cannot participate, he/she can indicate one of the co-authors to present the poster during the event.
– There will be a dedicated area in the virtual platform for each poster, which will include the abstract, the poster, the video, as well as space for questions and answers and other forms of interaction with the audience.
– The authors who have their posters selected must keep their profile in the event application active and updated, and be attentive to all contacts made by the Scientific and Technological Committee, the Independent Awards Evaluation Committee and other participants of the event interested in better understanding their work.
– The interaction with the authors both in the face-to-face exhibition and in the event’s app is fundamental to generate interest from the public, answer the questions of the Independent Awards Evaluation Commission, stimulate possible partnerships and collaborations and increase the visibility of the work.
– The interaction with the posters through the app will be fundamental for the work to compete for the Popular Poster Award, which will be given to the work most voted by the participants of the symposium through the app. Each author will receive a material to promote their work in the various means, either through social networks or direct contact with other participants of the 7th ISI, but can also create their own mechanisms and materials for dissemination and stimulation of visitation of their work to increase the chance of being awarded.
There will be an Independent Award Evaluation Committee, composed of researchers of recognized excellence, not affiliated with Fiocruz, who will evaluate the posters for awards.
All posters presented are eligible for awards, regardless of their selection for oral presentation in the plenary session. Criteria for the award are:
– The quality of the abstract and poster presented;
– The relevance of the work to scientific and technological development, production, quality assurance, management and regulation in the immunobiological area;
– The importance of the work for Brazilian and world public health.
The decisions of the Independent Award Committee will be sovereign and unappealable.
The three best papers submitted for participation in the Seminar will be chosen by the Independent Award Evaluation Committee and will receive a certificate, in addition to a cash prize (gross values):
1st place: Oswaldo Cruz Award – BRL 7000.00
2nd place: Carlos Chagas Award – BRL 5000.00
3rd place: Alcides Godoy Award – BRL 3000.00
Three other awards will be offered for the best Young Scientific Talent papers – submitted by authors up to 26 years old:
Henrique de Azevedo Penna Award – BRL 1,000.00
Evandro Chagas Award – BRL 1,000.00
Sérgio Arouca Award – BRL 1,000.00
The independent Awards Evaluation Committee may select other works to be highlighted through honorable mentions, without cash awards, if deemed necessary.
Since its last edition, the International Symposium on Immunobiologicals also counts with the Popular Poster Award, offered to the work most voted by participants through the event application. The winner receives a certificate, as well as BRL 1,000.00 in cash (gross values).
For publication of papers by Bio-Manguinhos collaborators, whether authors or co-authors, authorization from NIT-Bio is required. This authorization must be made on the abstract submission form, attaching the authorizations for publication given by the following entities: immediate superior and vice-director. These authorizations must be requested before the work is submitted to the Scientific Committee, so that they can be attached to the form.
Proof of registration of Genetic Heritage must also be attached to the form, when applicable.
6th International Symposium on Immunobiologicals
1º lugar – Prêmio Oswaldo Cruz
Evaluation of antitumor activity of 5 RNA interference in conjunction for the treatment of breast cancer in nude mice
Ana Beatriz Teixeira Frederico
2º Lugar – Prêmio Carlos Chagas
Waste valorization through sustainable management at the Instituto de Tecnologia em Imunobiológicos – Bio-Manguinhos /Fiocruz. Case study
Raul Gonçalves Severo
3º Lugar – Prêmio Alcides Godoy
Transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves the cardiac performance
Roberto Rodrigues Ferreira
Jovem Talento – Prêmio Henrique de Azevedo Penna
Albuquerque Aragão
Piggybac transposon-based production of anti-HER2 CAR T cell
Emmanuel Arthur
Jovem Talento – Prêmio Evandro Chagas
A significant portion of undergraduate health science students are not immunized as they should
Claudia Lamarca Vitral
Jovem Talento – Prêmio Sergio Arouca
Determination of neutralizing antibodies to SARS-COV-2 by recombinant pseudovirus methodology in a cohort of patients with mild to moderate infection and/or vaccinated
Sarah Aparecida Rodrigues Sérgio
Prêmio Votação Popular
Median Tissue Culture Infectious Dose (TCID50) as a validated tool to measure antiviral activity in functionalized textiles
Adriana de Souza Azevedo Soares
Menção Honrosa
The benefits of empathetic leadership in the work environment – a case study: laboratory of virological technology (latev)
Liliane Regina da S. Ivan
Menção Honrosa
The cellular response elicited by ChAdOx1 nCoV-19 (Astrazeneca) vaccine in a cohort from Rio de Janeiro, Brazil with or without previous SARS-CoV-2 infection
Tamiris Azamor da Costa Barros
Menção Honrosa
bLf-PrP interaction: the antiprion effect of bovine lactoferrin
Caroline Augusto Barros
Premiação Innovation Hub – Escape Game
Rosana Moura de Andrade
V International Symposium on Immunobiologicals – 2021
1st place – Oswaldo Cruz Award
VAC-16 | Duration of immunity in volunteers ten years after a dose-response yellow fever vaccine study
Tatiana Guimarães de Noronha
2nd place – Carlos Chagas Award
OTR-19 | Congenital zika syndrome is associated with interferon alfa receptor 1
Tamiris Azamor
3rd place – Alcides Godoy Award
REA-05 | Development of a R$1 molecular test for rapid and direct detection of chikungunya virus from patient and mosquito samples
Severino Jefferson R. Silva
Young Scientific Talent – Henrique de Azevedo Penna Award
VAC-18 | Evaluation of humoral and cellular immune response after heterologous prime-boost immunization against SARS-CoV-2
Patrick Prestes de Azevedo
Young Scientific Talent – Evandro Chagas Award
REA-10 | Development of a rapid test for detection of anti-covid-19 IgG and IgM antibodies
Thiciany Blener Lopes
Young Scientific Talent – Alcides Godoy Award
BIO-15 | Tool development for analysis of scFv NGS data in databases related to 3d structures: evolution of antibodies in silico
Mathias Coelho Batista
Posters Popular
BIO-02 | Production of a monoclonal antibody against SARS-CoV-2 and determination of viral neutralization capacity
Nathalie Bonatti Franco Almeida
Honorable Mention
OTR-25 | EBV and HHV-6 infection in multiple sclerosis: search infection in multiple sclerosis: search for possible association with clinical phenotypes
Jéssica Gonçalves Pereira
Honorable Mention
VAC-14 | Immunogenicity of a 17-DD yellow fever vaccine in a dengue and zika endemic area of Paraiba state, Brazil
Luiz Antonio Camacho
Honorable Mention
VAC-11 | Disruption of active trans-sialidase genes impairs the egress from mammalian host cells and generates highly attenuated trypanosoma cruzi parasites
Gabriela de A. Burle-caldas
IV International Symposium on Immunobiologicals – 2019
1st place – Oswaldo Cruz Award
A fully automated lab-on-a-chip platform for arboviral diagnosis
Luis Gustavo Morello
2nd place – Carlos Chagas Award
Leishmania Infatum lipophosphoglycan, a novel carbohydrate-base antigen for the immunodignosis visceral leishmaniasis
Rodrigo Pedro Soares
3rd place – Alcides Godoy Award
Reduction of the cycle of lyophilization of the vaccine Atenuated Yellow Fever presentation 02 and 05 doses of Bio-Manguinhos
Patrícia Alvarenga Agra
Young Scientific Talent – Henrique de Azevedo Penna Award
Development and Validation of Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) for Rapid Detection of ZIKV in Human Samples
Severino Jefferson Ribeiro da Silva
Young Scientific Talent – Evandro Chagas Award
Evaluation of the antitumor effect of Natural Killer cells expressing Chimeric Antigen Receptors (CAR) against murine melanoma cells
Mariana Saldanha Viegas Duarte
Young Scientific Talent – Alcides Godoy Award
Evaluation of humoral imune response against Streptococcus pneumoniae elicited by vaccination of mice with a recombinant influenza virus
Kimberly Freitas Cardoso
Honorable Mention
The role of technological roadmaps in shaping the future strategy for Bio-Manguinhos
Lethícia Mallet
Honorable Mention
Developing an intranasal vaccine against canine visceral leishmaniasis: a study of efficacy in mice
Isabella P. Da Silva Bezerra
Honorable Mention
Genetic basis for Yellow Fever Vaccine-associated viscerotropic disease (YEL-AVD): a preliminary report
Emerson Cicilini Mesquita
VI Seminário Anual Científico e Tecnológico – 2018
1st place – Oswaldo Cruz Award
OTR-24 | Clinical, laboratory and sonographic follow-up of Zika virus (ZIKV) infection in Macaca mullata pregnant rhesus macaque treated with sofosbuvir
Noemi Rovaris Gardinali
2nd place – Carlos Chagas Award
OTR-22 | Immune landscape in esophageal squamous cell carcinoma
Luciana Rodrigues Carvalho Barros
3rd place – Alcides Godoy Award
VAC-03 | Estudo fase I, de segurança e imunogenicidade, da vacina dupla viral, para sarampo e rubéola, em adultos jovens
Eliane Matos dos Santos
Young Scientific Talent – Evandro Chagas Award
OTR-12 | Padronização de teste de neutralização por redução de focos (FRNT) para Zika como alternativa ao teste padrão-ouro PRNT.
José Henrique Rezende Linhares
Young Scientific Talent – Sergio Arouca Award
GES-10 | Mapeamento e avaliação dos perigos e pontos críticos de controle da produção do IFA de rubéola para vacina tríplice viral
Celina Vieira da Cunha Guedes Alvarenga
Young Scientific Talent – Henrique de Azevedo Penna Award
REA-11 | Seleção e caracterização de aptâmeros contra proteína PBP2a para o diagnóstico de infecção por Staphylococcus aureus resistente à meticilina
Laís Nascimento Alves
Honorable Mention
GES-12 | Projeto de implantação de um sistema de gerenciamento de informações laboratoriais – LIMS
Felipe Mendes de Luca
Honorable Mention
OTR-20 | Production of chimeric antigen receptor (CAR)-T cells for preclinical testing using non-viral transposon vectors and a lymphoblastoid cell line (LCL)
Leonardo Chicaybam
Honorable Mention
VAC-02 | Perfil epidemiológico de cepas de Neisseria meningitidis sorogrupo C circulantes no Brasil no período pré e pós vacinal
Aline Carvalho de Azevedo
V Seminário Anual Científico e Tecnológico – 2017
1st place – Oswaldo Cruz Award
Aumento da capacidade produtiva do insumo farmacêutico ativo da vacina febre amarela atenuada de Bio-Manguinhos
Caroline Moura Ramirez
2nd place – Carlos Chagas Award
Avaliação da resposta celular e humoral induzida pela vacina meningocócica C conjugada desenvolvida em Bio-Manguinhos
Etiene Moreira Gabriel
3rd place – Alcides Godoy Award
Epitoma do vírus mayaro e aplicação em novos métodos diagnósticos
Paloma Napoleão Pêgo
Young Scientific Talent – Evandro Chagas Award
Analises estratégicas para minimizar reação cruzada em Teste de Neutralização por redução de Placas de Lise do vírus da zika
Stephanie Almeida da Silva
Young Scientific Talent – Sergio Arouca Award
Viabilidade do uso de 1,10 fenantrolina e aptâmeros anti-MUC1 como radiossensibilizadores em células de câncer de mamas
Laís Nascimento Alves
Young Scientific Talent – Henrique de Azevedo Penna Award
Generation of a scFv antagonistic to VLA-4 integrin as potential therapeutic target in muscular dystrophies: in silico phasetor
Beatriz Chaves
Honorable Mention
Ferramenta de criticidade para o processo decisório da gestão de manutenção de equipamentos de controle de qualidade no caso Alfaepoetina
Aline da Silva Lima
Honorable Mention
Challenges in Influenza B in Brazil: from vaccine mismatches to viral evolutionary dynamics
Maria de Lourdes Aguiar Oliveira
Honorable Mention
Obtenção da proteína recombinante E2 do vírus chikungunya como insumo para o desenvolvimento de um novo teste diagnóstico
Carolina Lessa-Aquino
